The University of Toronto will use the decentralized funding platform to fund hallucinogenic drug research

According to foreign media, the University of Toronto's Mississauga Campus (UTM) is using a decentralized funding platform to fund a study on the hallucinogenic psilocybin. It is said that this is the first attempt to use decentralized funding to fund clinical trials of hallucinogens.